Concepedia

Kaisa Laapas

KL

4

Publications

211

Citations

4

H-Index

2017

Active since

Affiliations

Bayer (Germany)(Current)

Charles University

Bayer (Finland)

Medical University of South Carolina

University College London

Kaisa Laapas is an author at Bayer (Germany) specializing in translational research, clinical trials, and medicine.

Top concepts

Publications per year

2017–2025

4

Publications

4

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

Dinesh Khanna, Yannick Allanore, Christopher P. Denton et al. · Annals of the Rheumatic Diseases · 2020 · 104 citations · Full text

Dexmedetomidine oromucosal gel for noise‐associated acute anxiety and fear in dogs—a randomised, double‐blind, placebo‐controlled clinical study

Mira Korpivaara, Kaisa Laapas, Mirja Huhtinen et al. · Veterinary Record · 2017 · 77 citations · Full text

Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

Fátima Cardoso, Susanne Parke, Donal J. Brennan et al. · New England Journal of Medicine · 2025 · 18 citations

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial

Oliver Distler, Yannick Allanore, Christopher P. Denton et al. · The Lancet Rheumatology · 2023 · 12 citations

, , +8

Rows per page

1–4 of 4